Myocardial ischemia elicits an enhanced responsivity to a,-adrenergic stimulation and a reversible increase in a1-adrenergic receptor number. In adult cardiac myocytes, a1-adrenergic receptor number increases two-to threefold after 10 min of hypoxia, an increase similar to that seen during ischemia in vivo. To determine whether this increase in a1-adrenergic receptor number leads to an enhanced synthesis of inositol trisphosphate, the intracellular second messenger for the a,-adrenergic receptor, the mass of inositol trisphosphate was quantified by a novel procedure developed in our laboratory that circumvents problems associated with using labeled precursors. The peak increases in inositol trisphosphate levels of three-to fourfold were measured after 30 s of norepinephrine stimulation and exhibited a 50% effective concentration (EC50) of 7.9 X 10-8 M. Hypoxia produced a marked leftward shift in the dose-response curve for the production of inositol trisphosphate in response to norepinephrine stimulation (EC50 = 1.2 X 10-8 M). Hypoxia also induced a 100-fold reduction in the concentration of norepinephrine required to elicit a threshold increase in inositol trisphosphate (10-9 M), compared with control normoxic myocytes (10-7 M). Thus, hypoxia, which increases a1-adrenergic receptor density, also leads to an enhanced production of inositol trisphosphate and could account for the enhanced a1-adrenergic responsivity in the ischemic heart in vivo, which is known to facilitate arrhythmogenesis.
Introduction
Myocardial ischemia results in an increase in responsivity to al-adrenergic stimulation, which contributes to the development of malignant ventricular arrhythmias (1) . These lethal arrhythmias result from both reentrant and nonreentrant mechanisms (2, 3) . The nonreentrant mechanisms are largely unknown, but may involve the development of delayed afterdepolarizations resulting in triggered rhythms secondary to an increase in intracellular calcium. Blockade of a,-adrenergic receptors has been shown to inhibit the production of delayed afterdepolarizations under hypoxic conditions in vitro (4) and the accumulation of intracellular calcium after reperfusion in vivo (5) . Therefore, it is likely that enhanced a,-adrenergic input increases intracellular calcium, resulting in the occurrence of cardiac arrhythmias due to a nonreentrant mechanism. This increase in a,-adrenergic responsivity during early ischemia is associated with a twofold reversible increase in a,-adrenergic receptors (6) . The mechanisms responsible for the increase in a,-adrenergic receptors has recently been explored with the use of isolated adult canine myocytes exposed to hypoxia as an in vitro model of myocardial ischemia. Acute hypoxia produced a two-to threefold reversible increase in cell surface a,-adrenergic receptors secondary to the sarcolemmal accumulation of long-chain acylcarnitines (7) . A critical question is whether these newly exposed receptors are linked to an intracellular second messenger that could contribute to the increase in intracellular calcium.
The intracellular second messengers mediating a,-adrenergic stimulation in many tissue types are inositol (1, 4, 5) trisphosphate (IP3)' (8) and diacylglycerol produced through cleavage of phosphatidylinositol (4, 5) -bisphosphate by phospholipase C. IP3 increases the concentration of cytosolic Ca2l (9) , whereas diacylglycerol activates protein kinase C (10) , which may also increase cytosolic Ca2l by phosphorylating sarcolemmal calcium channels (11 (12, 13) , although only after prolonged stimulation and in the presence of pharmacologic interventions. This study was performed to determine first whether a,-adrenergic stimulation elicits an increase in the production of IP3 in adult cardiac myocytes under normoxic conditions using a method developed in our laboratory and based in part on that of Rittenhouse and Sasson (14) to measure directly the mass of inositol phosphates. The second objective was to assess whether this response was altered by hypoxia.
Methods
The isolated adult canine myocyte preparation has been characterized extensively with the use of biochemical, electrophysiologic, and histo-logic endpoints (7 (1. 0 Ci/mmol) with subsequent ion-exchange chromatography as described above to determine the amount of radioactivity in the individual inositol fractions. After dephosphorylation, 1 nmol of chiro-inositol was added to each sample to serve as an internal standard for gas chromatographic analysis.
Desalting inositolfractions. Samples were desalted using an extensively washed mixed-bed anion-cation exchange resin (MSZ 501, 20-50 mesh, Bio-Rad Laboratories). Inositol was eluted with 8 ml of distilled water. The eluate was collected in 13 X 100 mm siliconized glass tubes.
Derivatization and gas chromatography. After desalting, samples were lyophilized to dryness under vacuum followed by derivatization to the hexatrimethylsilyl derivatives. This was achieved by the addition of25 Ml ofanhydrous pyridine (Aldrich Chemical Co., Milwaukee, WI) and 25 M1 of bis-(trimethylsilyl) trifluoroacetamide with 1% trimethylchlorosilane (Pierce Chemical Co., Rockford, IL) to each dried residue. Samples were vortexed and transferred to 0.3-ml glass reactivials (Pierce Chemical Co.). Reactivials were capped and placed in a heating block at 60°C overnight. Separation of chiro-and myo-inositol was achieved by gas chromatography using a gas chromatograph model 3700 (Varian Associates, Inc., Palo Alto, CA The greatest loss occurred during desalting (30%). However, because chiro-inositol was added to the samples as an internal standard before this step, this loss of myo-inositol only represents a loss of signal to noise and does not enter into the calculation of inositol mass. Complete derivatization of both chiro-and myo-inositol standards (10 nmol of each) was achieved after 5 h of incubation at 60°C. The detector response ratio to chiro-and myo-inositol at the gas chromatographic settings described in Methods was found to be 1.51. Excellent linearity was also found between the detector response and increasing amounts of myo-inositol (r = 0.999).
Inositol trisphosphate response. Initial studies were aimed at assessing the inositol phosphate response of isolated adult canine myocytes to stimulation by norepinephrine. The levels of IP3, IP2, and IP, after norepinephrine stimulation are shown in Fig. 1 . An initial increase in IP3 was apparent as early (17) indicated that both isomers were present in low levels before stimulation (8 pmol/mg protein for (1,3,4)1P3 and 12 pmol/mg protein for (1,4,5)IP3). In contrast, stimulation with norepinephrine for 30 s resulted in a selective increase in the (1,4,5)IP3 isomer (48 pmol/mg protein), indicating production of the physiologically active isomer, which can mobilize intracellular calcium in several cell systems (9) .
To determine whether the norepinephrine-induced increase in IP3 was mediated specifically through the a1-adrenergic receptor, myocytes were stimulated with norepinephrine for 30 s in the absence or presence of specific a,-, a2-, and fl-adrenergic antagonists (Fig. 2) . As with the time course experiment, norepinephrine produced a threefold increase in IP3 levels. The stimulation of IP3 by norepinephrine was completely inhibited by the specific a,-adrenergic antagonist BE-2254; yohimbine (a2-adrenergic antagonist) or propranolol (I3-and #2-adrenergic antagonist) had no significant effect, thereby conferring an aC-adrenergic specificity to the IP3 response.
The dose-response curve for IP3 production was then as- (Fig. 3, inset) Normoxic Myocytes * Hypoxia was produced by degassing Hepes buffer (pH = 7.2) followed by equilibration with prepurified N2 for 3 h. Myocytes were introduced into an air-tight vial under N2, which was blown continuously over the myocyte suspension. Values for IP3 production from normoxic and hypoxic myocytes given above are the mean±SEM from four separate experiments. Statistical significance (P < 0.05) of the difference between each norepinephrine-stimulated value and the corresponding hypoxic or normoxic control value was assessed by analysis of variance followed by Duncan's test, and is denoted by an asterisk. The EC, for each curve was obtained by normalization of the data and calculation of the norepinephrine concentration giving half the maximum response. There was a significant difference between the normoxic and hypoxic dose-response curves (P < 0.001), as determined by analysis of covariance.
centration of norepinephrine giving half-maximal response) was determined as 7.9±0.9 X 10-8 M. This EC50 value for norepinephrine stimulation of IP3 is considerably lower than the EC50 for norepinephrine displacement of specific [3H]prazosin binding (1.6±0.7 X 10-6 M) on adult canine myocytes (7). This finding indicates that a maximal IP3 response can be elicited by occupancy of a small fraction of the a1-adrenergic receptors on adult canine myocytes. This phenomenon could be explained by a vast excess of a1-adrenergic receptors or "spare receptors" on the myocytes. Alternatively, there may be several subtypes of a I-adrenergic receptors on these cells, all of which would be detected by [3H]prazosin binding but only some of which may be functionally coupled to IP3 production. We have characterized previously the biochemical and morphologic response of adult canine myocytes to selected intervals of hypoxia (7) . Hypoxia of 20 min or less at 370C is associated with reversible alterations, as assessed by ATP and creatine phosphate content, a lack of intracellular enzyme release, and a lack of membrane disruption assessed using electron microscopy. More prolonged periods of hypoxia (> 20 min) are associated with release of intracellular enzymes and gross morphologic disruption indicative of irreversible cellular damage. Hypoxic intervals of 1O min result in a two-to threefold reversible increase in a1-adrenergic receptor number (7) . To determine whether this increase in a,-adrenergic receptors is coupled to an increase in the IP3 response, myocytes were exposed to hypoxia (Po2 < 15 mmHg, 370C) for 10 min and then stimulated with selected concentrations of norepinephrine, followed by measurement of the content of IP3 (Fig. 3 ). An initial time course of IP3 production after norepinephrine (10-5 M) stimulation of hypoxic myocytes verified that the peak increase again occurred at 30 s (data not shown). Hypoxic myocytes demonstrated a dramatic increase in the production of IP3 compared with production in normoxic myocytes after stimulation with submaximal concentrations of norepinephrine. The EC50 for norepinephrine stimulation in hypoxic cells was 1.2±0.9 X 10-8 M, sixfold lower than that obtained from the dose-response curve in normoxic cells. Most importantly, the threshold concentration of norepinephrine required to produce a significant increase in IP3 was 10-9 M in hypoxic myocytes and 100-fold higher (I -' M) in normoxic myocytes. However, there was no significant difference between the maximum IP3 level produced when hypoxic and normoxic myocytes were exposed to the highest concentration of norepinephrine (10-5 M) . Therefore, at submaximal concentrations of norepinephrine, a greater IP3 response is induced in hypoxic compared with normoxic myocytes. This difference is particularly evident in the physiologic range of norepinephrine concentrations (i010 to 10-8 M). Indeed, exposure of the myocytes to hypoxia has shifted the IP3 response to a,-adrenergic stimulation into the physiologic range of norepinephrine concentrations.
Discussion
These data indicate that the increase in a1-adrenergic receptor number in response to acute hypoxia is concurrent with a greater IP3 response after stimulation by norepinephrine. In many systems, there are more receptors present than are required for a maximum response and can be referred to as spare but equivalent receptors. In these systems, increased receptor number can produce a leftward shift in the dose-response curve with no change in maximum response, similar to results found in this study. Thus, regulation of receptor number can provide a mechanism for control of cell responsiveness. Although increased exposure of aI-adrenergic receptors probably accounts for at least a portion of the increased IP3 response, a number of other factors may also be operative. The increased fluidity of the sarcolemmal membrane during hypoxia, facilitated by the sarcolemmal accumulation of long-chain acylcarnitines (7, 18) , could enhance coupling between the a1-adrenergic receptor and phospholipase C or an activator of phospholipase C, possibly a guanine nucleotide-binding protein (G protein). However, direct identification of the G protein involved has not been reported. If coupling of a1-adrenergic receptors to IP3 production relies on the collision coupling of receptor, G protein, and phospholipase C, increased membrane fluidity could enhance this coupling. Alternatively, enhanced IP3 production may result from a component of the coupling system remaining in an active configuration for a longer period of time. The dramatic difference between the IP3 response in hypoxic compared with normoxic myocytes suggests that mechanisms other than the increase in a,-adrenergic receptor number may contribute to the increased IP3 response.
These results and findings in vivo demonstrate that the a1-adrenergic system in hypoxic or ischemic cardiac tissue is more responsive than that in normoxic cardiac tissue. Lindemann et al. (19) have shown that al-adrenergic stimulation leads to an increase in [32P]phosphate incorporation into a 1 5-kD sarcolemmal protein that has previously been identified as a substrate for protein kinase C (1 1). Phosphorylation was associated with restoration of contractions in hearts depolarized with elevated extracellular K+, which was probably mediated by the slow inward current carried by Ca2. A recent preliminary study indicates that norepinephrine only stimulates protein kinase C in depolarized cardiac tissue (20) and the authors speculate that al-adrenergic stimulation of protein kinase C may depend on membrane potential or the degree of calcium loading. Both IP3 production and activation of protein kinase C can result in an increase in the intracellular concentration of calcium. The increased al-adrenergic responsivity in the heart during ischemia probably results in an increase in the synthesis of IP3 and possibly activation of protein kinase C. By increasing the intracellular concentration of calcium, al-adrenergic stimulation may act as a secondary positive inotropic system in the failing heart, independent of adenylate cyclase. However, increased intracellular calcium may contribute to the development of triggered rhythms. Activation of this aI-adrenergic mechanism leading to enhanced production of IP3 could be an important mediator of malignant cardiac arrhythmias leading to sudden cardiac death.
